Krystal Biotech buy Guggenheim
Start price
25.02.26
/
50%
€233.30
Target price
25.02.27
€240.95
Performance (%)
36.99%
Price
22:25
€319.60
Summary
This prediction is currently active. With a performance of 36.99% the BUY prediction by Guggenheim is a big success. This prediction currently runs until 25.02.27. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Krystal Biotech | 4.276% | 4.276% |
| iShares Core DAX® | 2,99 % | 3,22 % |
| iShares Nasdaq 100 | -1,58 % | -3,17 % |
| iShares Nikkei 225® | -2,25 % | -9,92 % |
| iShares S&P 500 | -0,01 % | 1,64 % |
Comments by Guggenheim for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech (KRYS) had its price target raised by Guggenheim from $224.00 to $284.00. They now have a "buy" rating on the stock.
Ratings data for KRYS provided by MarketBeat
Stopped prediction by Guggenheim for Krystal Biotech
Krystal Biotech
Start price
Target price
Perf. (%)
€120.90
07.05.25
07.05.25
€166.60
07.05.26
07.05.26
113.56%
08.05.26
08.05.26
Krystal Biotech
Start price
Target price
Perf. (%)
€152.00
27.02.24
27.02.24
€161.18
27.02.25
27.02.25
14.14%
28.02.25
28.02.25